Can patients maintain their use of everolimus until lung transplantation?

Transplantation. 2015 Jun;99(6):e42-3. doi: 10.1097/TP.0000000000000722.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Calcineurin Inhibitors / adverse effects
  • Everolimus
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Lung Transplantation* / adverse effects
  • Male
  • Reoperation
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use
  • TOR Serine-Threonine Kinases / antagonists & inhibitors

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Everolimus
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus